One-time Roche Diagnostics marketing chief takes on managing director role for Razorfish Health

NEW YORK - David Paragamian has been named managing director for Razorfish Health, a division of Publicis Health. In his new role, effective immediately, Paragamian will be responsible for overseeing Razorfish Health businesses across North America, including offices in New York and Philadelphia.

Paragamian will report to Matt McNally, group president, Publicis Health.

"Dave's deep experience on both the client and agency sides of healthcare communications makes him the perfect leader to take Razorfish Health to the next level," McNally said. "I look forward to his contributions and leadership at Publicis Health."

"Healthcare communications has changed dramatically over the last few years and the transformation of our business will only continue to accelerate," said Paragamian. "Razorfish Health's positioning as a unique health and wellness agency with the deepest digital roots, strong analytics and outstanding creative makes us a unique full-service partner to drive our clients' brands now and into the future. I'm delighted to join the Publicis Health family."

Paragamian began his career in brand management at Procter & Gamble. He also worked as a product director at the McNeil unit of Johnson & Johnson, then spent five years at Roche in a series of marketing and sales management roles leading to the head of both marketing and sales for Roche Diagnostics US.

Later, he moved to the agency side, leading several major global healthcare agencies, including as a partner and president of the flagship U.S. office of Havas Health, Euro RSCG Life LM&P and Huntsworth Health.

Paragamian is a published author on the subject of branding, a noted speaker on agency management and communications issues and an adjunct professor at St. Joseph's University Erivan Haub School of Business in Philadelphia, where he teaches product management.

He holds a B.A. Cum Laude from Hamilton College and an M.A. from La Salle University.